{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T10:44:08Z","timestamp":1790160248300,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,12]],"date-time":"2017-06-12T00:00:00Z","timestamp":1497225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Swedish Cancer Society","doi-asserted-by":"publisher","award":["CAN 2012\/891"],"award-info":[{"award-number":["CAN 2012\/891"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Swedish Cancer Society","doi-asserted-by":"publisher","award":["CAN2015\/652"],"award-info":[{"award-number":["CAN2015\/652"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Dr. \u00c5ke Olsson Foundation"},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007231","name":"Cancer Society in Stockholm","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007231","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007230","name":"King Gustaf V's Jubilee Foundation","doi-asserted-by":"publisher","award":["131192"],"award-info":[{"award-number":["131192"]}],"id":[{"id":"10.13039\/501100007230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007230","name":"King Gustaf V's Jubilee Foundation","doi-asserted-by":"publisher","award":["151241"],"award-info":[{"award-number":["151241"]}],"id":[{"id":"10.13039\/501100007230","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swedish Childhood Cancer Society","award":["FoAss13\/015"],"award-info":[{"award-number":["FoAss13\/015"]}]},{"name":"Swedish Childhood Cancer Society","award":["PROJ12\/081"],"award-info":[{"award-number":["PROJ12\/081"]}]},{"name":"Karolinska Institute Wallenberg Institute for Regenerative Medicine"},{"DOI":"10.13039\/501100002794","name":"Swedish Cancer Society","doi-asserted-by":"publisher","award":["CAN 2010\/590"],"award-info":[{"award-number":["CAN 2010\/590"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2008-19616-59131-19"],"award-info":[{"award-number":["2008-19616-59131-19"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006738","name":"Medical Faculty, Lund University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011077","name":"Sk\u00e5ne University Hospital","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011077","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Gunnar Nilsson Foundation"},{"name":"John Persson Foundation"},{"name":"Gunnel Bj\u00f6rk Foundation"},{"name":"Georg Danielsson Foundation"},{"name":"Finnish Cancer Institute"},{"name":"Finnish Cancer Societies"},{"DOI":"10.13039\/501100004325","name":"Signe and Ane Gyllenberg Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.bbrc.2017.06.051","type":"journal-article","created":{"date-parts":[[2017,6,13]],"date-time":"2017-06-13T21:16:07Z","timestamp":1497388567000},"page":"378-384","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Leukotriene signaling via ALOX5 and cysteinyl leukotriene receptor 1 is dispensable for in\u00a0vitro growth of CD34+CD38\u2212 stem and progenitor cells in chronic myeloid leukemia"],"prefix":"10.1016","volume":"490","author":[{"given":"Monika","family":"Dolinska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Piccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Man","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Gelali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sofie","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannis","family":"Klang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingnan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Yektaei-Karin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulla Olsson","family":"Str\u00f6mberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0816-8241","authenticated-orcid":false,"given":"Satu","family":"Mustjoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif","family":"Stenke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marja","family":"Ekblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2512-9199","authenticated-orcid":false,"given":"Hong","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2017.06.051_bib1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrc2368","article-title":"Getting to the stem of chronic myeloid leukaemia","volume":"8","author":"Savona","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2017.06.051_bib2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s13238-015-0143-7","article-title":"Leukemia stem cells: the root of chronic myeloid leukemia","volume":"6","author":"Zhou","year":"2015","journal-title":"Protein Cell"},{"key":"10.1016\/j.bbrc.2017.06.051_bib3","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1182\/blood-2002-09-2780","article-title":"Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment","volume":"101","author":"Bhatia","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2017.06.051_bib4","doi-asserted-by":"crossref","first-page":"891","DOI":"10.4049\/jimmunol.1501648","article-title":"Deletion of 5-lipoxygenase in the tumor microenvironment promotes lung cancer progression and metastasis through regulating T cell recruitment","volume":"196","author":"Poczobutt","year":"2016","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.bbrc.2017.06.051_bib5","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJMra071371","article-title":"Leukotrienes","volume":"357","author":"Peters-Golden","year":"2007","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2017.06.051_bib6","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/ng.389","article-title":"Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia","volume":"41","author":"Chen","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2017.06.051_bib7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrc3317","article-title":"Pushing the limits of targeted therapy in chronic myeloid leukaemia","volume":"12","author":"O'Hare","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2017.06.051_bib8","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.3324\/haematol.2013.101972","article-title":"Low leukotriene B4 receptor 1 leads to ALOX5 downregulation at diagnosis of chronic myeloid leukemia","volume":"99","author":"Lucas","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.bbrc.2017.06.051_bib9","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/j.1365-2141.2008.07283.x","article-title":"Clinical imatinib mesylate treatment induces early normalisation of aberrant neutrophil leukotriene C4 synthase expression and activity in chronic myeloid leukaemia","volume":"142","author":"Roos","year":"2008","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bbrc.2017.06.051_bib10","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1182\/blood.V95.4.1456.004k06_1456_1464","article-title":"Aberrant expression of active leukotriene C(4) synthase in CD16(+) neutrophils from patients with chronic myeloid leukemia","volume":"95","author":"Sjolinder","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2017.06.051_bib11","first-page":"1","article-title":"Modulation of leukotriene signaling inhibiting cell growth in chronic myeloid leukemia","author":"Yektaei-Karin","year":"2016","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.bbrc.2017.06.051_bib12","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/blood-2013-05-501569","article-title":"European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013","volume":"122","author":"Baccarani","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2017.06.051_bib13","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1182\/blood.V88.10.3765.bloodjournal88103765","article-title":"Enhanced detection, maintenance, and differentiation of primitive human hematopoietic cells in cultures containing murine fibroblasts engineered to produce human steel factor, interleukin-3, and granulocyte colony-stimulating factor","volume":"88","author":"Hogge","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2017.06.051_bib14","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/leu.2015.300","article-title":"A\u00a0novel Lin-CD34+CD38- integrin alpha2- bipotential megakaryocyte-erythrocyte progenitor population in the human bone marrow","volume":"30","author":"Wong","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.bbrc.2017.06.051_bib15","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/MCB.01287-12","article-title":"Molecular characterization of prospectively isolated multipotent mesenchymal progenitors provides new insight into the cellular identity of mesenchymal stem cells in mouse bone marrow","volume":"33","author":"Qian","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbrc.2017.06.051_bib17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1182\/blood.V112.11.193.193","article-title":"Differentially expressed and novel transcripts in highly purified chronic phase CML stem cells","volume":"112","author":"Zhao","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2017.06.051_bib18","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/sj.leu.2404609","article-title":"Chronic myeloid leukemia stem cells possess multiple unique features of resistance to BCR-ABL targeted therapies","volume":"21","author":"Jiang","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.bbrc.2017.06.051_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fcell.2016.00103","article-title":"Evaluation of cysteinyl leukotriene signaling as a therapeutic target for colorectal cancer","volume":"4","author":"Burke","year":"2016","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbrc.2017.06.051_bib20","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.bbrc.2016.03.018","article-title":"Targeting of the BLT2 in chronic myeloid leukemia inhibits leukemia stem\/progenitor cell function","volume":"472","author":"Xiao","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2017.06.051_bib21","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3109\/10428194.2011.625578","article-title":"The G protein-coupled receptor CysLT1 mediates chemokine-like effects and prolongs survival in chronic lymphocytic leukemia","volume":"53","author":"Drost","year":"2012","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.bbrc.2017.06.051_bib22","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1182\/blood.V97.11.3433","article-title":"Chemotaxis and transendothelial migration of CD34(+) hematopoietic progenitor cells induced by the inflammatory mediator leukotriene D4 are mediated by the 7-transmembrane receptor CysLT1","volume":"97","author":"Bautz","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2017.06.051_bib23","doi-asserted-by":"crossref","first-page":"6789","DOI":"10.4049\/jimmunol.0801525","article-title":"The CysLT1 ligand leukotriene D4 supports alpha4beta1- and alpha5beta1-mediated adhesion and proliferation of CD34+ hematopoietic progenitor cells","volume":"182","author":"Boehmler","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.bbrc.2017.06.051_bib24","doi-asserted-by":"crossref","first-page":"8296","DOI":"10.1073\/pnas.0903851106","article-title":"Transcellular biosynthesis of cysteinyl leukotrienes in\u00a0vivo during mouse peritoneal inflammation","volume":"106","author":"Zarini","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1731183X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1731183X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T16:51:16Z","timestamp":1655484676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X1731183X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0006291X1731183X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2017.06.051","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leukotriene signaling via ALOX5 and cysteinyl leukotriene receptor 1 is dispensable for in\u00a0vitro growth of CD34+CD38\u2212 stem and progenitor cells in chronic myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2017.06.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}